3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to R Mohan.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
PURPOSE: To develop computer software that assists the planner avoid potential gantry collisions with the patient or patient support assembly during the treatment planning process. METHODS AND MATERIALS: The approach uses a simulation of the therapy room with a scale model of the treatment machine. Because the dimensions of the machine and patient are known, one can calculate a priori whether any desired therapy field is possible or will result in a collision. To assist the planner, we have developed a graphical interface enabling the accurate visualization of each treatment field configuration within a "room's eye view" treatment planning window. This enables the planner to be aware of, and alleviate any potential collision hazards. To circumvent blind spots in the graphic representation, an analytical software module precomputes whether each update of the gantry or turntable position is safe. RESULTS: If a collision is detected, the module alerts the planner and suggests collision evasive actions such as either an extended distance treatment or the gantry angle of closest approach. CONCLUSIONS: The model enables the planner to experiment with unconventional noncoplanar treatment fields, and immediately test their feasibility.
PURPOSE: Three dimensional conformal radiation treatments are complex, often involving large numbers of blocked or multileaf collimated fields that shape regions of high dose to conform to the treatment volume. As manual definition and digitization of aperture shapes and their corresponding multileaf configurations can be impractically time consuming, it was necessary to integrate the planning of multileaf fields into an existing three dimensional treatment planning system and improve the efficiency of treatment delivery to make these treatments feasible on a routine basis. METHODS AND MATERIALS: A subfunction of the Beam's Eye View (BEV) component can be used to automatically generate a continuous aperture shape with a margin around the tumor to account for beam penumbra, and excluding any normal structures to be spared (each with its own margin). To convert a continuous aperture shape into one defined by the multileaf collimator (MLC), a leaf coverage mode is chosen to determine how leaves are fitted to aperture shapes. The conversion process also considers parameters of the specific MLC system, e.g., leaf thickness and the number of leaves. If normal structures to be shielded split the target into multiple regions, more than one multileaf aperture can result. An interactive leaf adjustment routine is also provided to allow for modification of individual leaf positions. Dose calculation programs then take into account multileaf apertures for computation of dose distributions using a pencil beam convolution model. Finally, prescription files specifying leaf and jaw configurations are prepared in treatment machine specific formats and downloaded to the computers driving the multileaf collimators and other components of the treatment machines. RESULTS AND CONCLUSION: An example is presented of a prostate treatment plan, with MLC configurations, dose distributions, and treatment delivery description, along with discussion of clinical implementation at Memorial Hospital.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Erythrocytes isolated from 131 cases of Non-Insulin Dependent Diabetes Mellitus (NIDDM) were studied for lipid peroxidation, antioxidant defences, and the maximum peroxidisable substrate in the cell membrane. Antioxidant defences are lowered in NIDDM, followed by significant rise in lipid peroxidation products. However, in the erythrocyte membrane, the total polyunsaturated peroxidisable lipids are lower than in normal erythrocytes which may be a causative factor affecting the survival of the cells.
Explore the source record for details and available documents.
To overcome the limitations of the intensity modulation optimization techniques based on dose criteria, we introduce a method for optimizing intensity distributions in which we employ an objective function based on biological indices. The objective function also includes constraints on dose and dose-volume combinations to ensure that the results are consistent with the physician's judgement. We apply a variant of the steepest-descent method to optimize the objective function. The method is three-dimensional and incorporates scattered radiation in the optimization process using an iterative scheme employing the pencil beam convolution method. Previously we had shown that the inverse technique of obtaining optimum intensity distributions, for which the objectives are defined in terms of a desired uniform dose to the target volume and desired upper limits of dose to normal organs, produces satisfactory approximations of the desired dose distributions for prostate plans. However, for lung, the performance of this technique was considerably inferior. Our conclusion was that, in general, it is not sufficient to specify the objectives of optimization purely in terms of a desired pattern of dose and that the objectives should also incorporate biology, perhaps in the form of biological indices. We demonstrate that the biology-based approach produces lung plans that are superior to those produced when only dose-based objectives are used. For the treatment of prostate, the two methods produce comparable dose distributions.
Three-dimensional (3-D) conformal treatments are complex and involve many fields, virtually all of which are irregularly shaped and, in the not too distant future, may be intensity-modulated arbitrarily. The multileaf collimator (MLC) is an essential tool for making the delivery of these treatments practical. The characteristics of MLCs of different manufacturers vary significantly, which has an impact on the resulting dose distributions and their clinical applicability. The jagged edges of the fields shaped with MLCs has raised concern about the dose distributions. To study the dosimetric consequences of the jagged boundary, accurate methods of predicting dose distributions are necessary. Preliminary dosimetric and clinical studies show that, for a vast majority of sites and techniques, the MLC is an appropriate replacement for continuous alloy blocks and that the uneasiness about the MLC-shaped boundaries is unwarranted. To fully realize the efficiency possible with a MLC, it is important that it be integrated into the 3-D conformal treatment planning system. Schemes and criteria for positioning leaves relative to the continuous boundary are being studied and often depend on the treatment site, the surrounding normal critical structures, and the treatment technique. Optimum use of the MLC for the efficient delivery of complex 3-D conformal treatments is possible only when treatments are delivered under computer control. Computer-controlled radiation therapy with the MLC is evolving rapidly. Currently, only boundaries are shaped automatically. It is expected that in the near future intensity-modulated treatments will also become practical. General quality assurance and safety requirements of a treatment machine. In many ways, MLCs are more precise and safer than conventional field-shaping devices. However, it is important that the MLC configuration for each field be verified by a record and verify system to ensure that the correct field shape has been selected for treatment.
In contrast to the traditional treatment planning process where beam parameters are adjusted in order to produce a desired dose distribution, the inverse treatment planning technique starts from the desired dose distribution and employs mathematical inversion to derive a set of optimal intensity profiles for beams with predefined directions. Crucial to the success of the inverse technique is the mathematical inversion process that yields the optimized intensity modulation. This paper systematically investigates the influence of phantom scatter in the process of designing the optimized intensity modulation and assesses its clinical consequences through the resultant treatment plans. Optimized intensity modulations and the resultant dose distributions were calculated for four prostate patients and for a simple cubic phantom under two conditions: one includes scatter and the other ignores scatter in designing the optimized intensity modulation. The effects of scatter were assessed by comparing the isodose distributions, the dose-volume histograms of the target and of the critical organs, and the tumor control probabilities and the normal tissue complication probabilities of two set prostate treatment plans. The comparison reveals that the dose homogeneity to the target is significantly improved when scatter is included in the optimization process. For prostate patients, the dose to the volume enclosed by the outer rectal contour is concomitantly reduced. Our results suggest that it is important to include the scatter in the iterative design of the optimized intensity modulations.
The first of a new generation of microtron accelerators has been installed and tested. It is currently in use for multisegment conformal radiotherapy at our institution. The unit produces x rays and electrons from 10 to 50 MeV in 5 MeV increments. It incorporates a 64 leaf, doubly focused multileaf collimator (MLC), which can be used to shape x-ray and electron beams. Both x-ray and electron beams are produced by magnetically scanning the electron beams from the accelerator. The new generation unit incorporates a purging magnet to sweep away any primary or secondary electrons that pass through the target(s). In this paper, the beam characteristics of the accelerator that were studied during acceptance testing are described. Representative examples of depth doses, beam profiles, output factors, and elementary beam distributions are presented and discussed, in comparison with the earlier generation of microtron accelerators and with other radiotherapy machines.
A generic Monte Carlo model of a photon therapy machine is described. The model, known as McRad, is based on EGS4 and has been in use since 1991. Its primary function has been the characterization of the incident photon fluence for use by dose calculation algorithms. The accuracy of McRad is examined by comparing the dose distributions in a water phantom generated using only the Monte Carlo data with measured dose distributions for two machines in our clinic; a 6 MV Varian Clinac 600C and the 15 MV beam from a Clinac 2100C. The Monte Carlo generated dose distributions are computed using a dose calculation algorithm based on the use of differential pencil beam kernels. It was found that the match to measured data could be improved if the model is tuned by adjusting the energy of the electron beam incident on the target. The beam profiles were found to be more sensitive indicators of the electron beam energy than the depth dose curves. Beyond the depths reached by contaminant electrons, the computed and measured depth dose curves agree to better than 1%. The comparison of beam profiles indicate that in regions up to within 1 cm of the field edge, the measured and computed doses generally agree to within 2%-3%.
Cadherins are glycoproteins that are members of the superfamily of Ca(2+)-dependent cell adhesion molecules. They are located in the adherens junctions and play an important role in cell-cell interactions that influence cell polarity, cell migration, cell sorting, and morphogenesis. To gain a better understanding of the molecules that mediate cell-cell interactions in corneal epithelium, we wished to characterize the E-cadherin from rabbit corneal epithelium. Using degenerate primers designed against an extracellular region that is highly conserved between the E-cadherin cDNA sequences of mouse and human, reverse transcription-polymerase chain reaction (RT-PCR) was performed on RNA isolated from rabbit corneal epithelial cell cultures. A 381 bp rabbit E-cadherin cDNA fragment that was amplified, was cloned and sequenced. This rabbit E-cadherin cDNA fragment was used as a probe for northern blot analysis of rabbit corneal epithelial cell cultures and subsequently, to isolate rabbit E-cadherin cDNA clones from a rabbit corneal epithelial cDNA library constructed in lambda UniZAP. A 4.3 kb transcript was detected in the northern blots of poly(A) RNA from confluent rabbit corneal epithelial cell cultures. The coding sequence of the 4.3 kb full-length rabbit E-cadherin cDNA was determined from overlapping clones. The deduced 886 amino acid sequence of the rabbit E-cadherin cDNA shows linear organization of the polypeptide into an N-terminal prosequence, five extracellular repeating domains, a transmembrane region, and a cytoplasmic domain at the C-terminus. Thus the rabbit E-cadherin from cornea is a classical member of the cadherin family and shows about 90% amino acid similarity to mouse and human E-cadherins. In the present study, in addition to the characterization of the 4.3 kb rabbit E-cadherin cDNA, a 2.3 kb E-cadherin clone was also isolated from the cDNA library. The 2.3 kb truncated cDNA was found to lack the DNA sequences encoding the transmembrane, the cytoplasmic, and the third, fourth, and fifth extracellular domains that are present in the classical rabbit E-cadherin. Transcripts corresponding to the truncated E-cadherin cDNA were detected by RT-PCR amplification of rabbit corneal epithelial cell culture RNA, but could not be detected by northern analysis, suggesting that message for this putative truncated E-cadherin may be expressed at low levels.